Showing results (261-270 of 1,186) with videos related to
Sort By:
Pageof 119
Pharmaceutical Statistics|February 6, 2024
A case study: Assessing the efficacy of the revised dosage regimen via prediction model for recurrent event rate using biomarker dataAhrim Youn, Jiarui Chi, Yue Cui, et al.Pharmaceutical Statistics|May 19, 2024
Covariate adjustment and estimation of difference in proportions in randomized clinical trialsJialuo Liu, Dong XiPharmaceutical Statistics|June 10, 2024
Experimental design considerations and statistical analyses in preclinical tumor growth inhibition studiesVinicius Bonato, Szu-Yu Tang, Matilda Hsieh, et al.Pharmaceutical Statistics|June 5, 2024
Using an early outcome as the sole source of information of interim decisions regarding treatment effect on a long-term endpoint: The non-Gaussian caseLeandro Garcia Barrado, Tomasz BurzykowskiPharmaceutical Statistics|October 11, 2024
Balance Index to Determine the Follow-Up Duration of Oncology TrialsLei Yang, Feinan LuPharmaceutical Statistics|September 10, 2024
On Some Modeling Issues in Estimating Vaccine EfficacyMauro GaspariniPharmaceutical Statistics|August 8, 2023
Calculation of Phase 2 dose-finding study sample size for reliable Phase 3 dose selectionFang Liu, Qing Zhao, Anthony J Rodgers, et al.Pharmaceutical Statistics|October 24, 2024
Comparison of Prior Distributions for the Heterogeneity Parameter in a Rare Events Meta-Analysis of a Few StudiesMinghong Yao, Fan Mei, Kang Zou, et al.Pharmaceutical Statistics|March 11, 2026
Multiplicity Adjustment Methods for a Three-Way Crossover Bioequivalence StudyDavid Hinds, Stella Grosser, Wanjie SunPharmaceutical Statistics|March 18, 2026
Unblinded by the Night: Predictive Power for Complex Bayesian Adaptive Trials When Sight Privileges VaryByron J Gajewski, Jonathan Beall, Kaustubh Nimkar, et al.Pageof 119